University of Minnesota Hospital and ClinicBarry D. GarfinkelUniversity of Minnesota Hospital and ClinicKluwer Academic Publishers-Plenum PublishersJournal of Autism & Developmental DisordersRealmuto GM , Jenson JB , Reeve E. , Garfinkel BD . ( 1990 ) Growth hormone response to L-dopa and clonid...
4Centro di Eccellenza per la Ricerca Biomedica, Universita` degli Studi di Genova, Genova, Italy and 5Department of Neurology, University of Minnesota, Minneapolis, MN, USA *Corresponding author: P Stanzione, Neurofisiopatologia, IRCCS Fondazione S Lucia, Via Ardeatina 306, Roma 00133, Italy. ...
Research Service and GRECC, VA Medical Center, Minneapolis, Minnesota 55417 and Department of Psychiatry and the Graduate Program in Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, USAHUNG T. QUACHResearch Service and GRECC, VA Medical Center, Minneapolis, Minnesota 55417 and ...
University of MinnesotaSpringer USWebster, D, Mortimer, J (1977) Failure of L-dopa to relieve activated rigidity in Parkinson’s disease. Adv. Exp. Med. Biol. 90: pp. 297-313Webster DD, Mortimer JA: Failure of L-dopa to relieve activated rigidity in Parkinson's disease. Advances in ...
The protocol for the use of fenoldopam as a renal protective agent (performed at the University of Minnesota) involves starting an intravenous fenoldopam infusion 2 hours before the procedure at a rate of 0.1 渭g/kg/min and increasing the dose in increments of 0.1 渭g/kg/min every 20 ...